299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02722122 (ClinicalTrials.gov)	May 2016	23/3/2016	Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of A ...	A Proof-of-Concept, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Expl ...	Cystic Fibrosis	Drug: AIR DNase™	Protalix	NULL	Recruiting	12 Years	N/A	Both	15	Phase 2	Israel
2	NCT02605590 (ClinicalTrials.gov)	December 2015	10/11/2015	Safety, Tolerability and Pharmacokinetics Study of AIR DNAseAdministered by Inhalation to Healthy Ad ...	A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose and Multiple Ascending Dose St ...	Cystic Fibrosis (CF)	Drug: AIR DNase;Drug: Placebo	Protalix	NULL	Completed	18 Years	55 Years	Male	18	Phase 1	Israel

First Previous1Next Last